Clinical Trial Update: Selinexor, Pomalidomide, and Dexamethasone For Multiple Myeloma With CNS Involvement [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating selinexor, pomalidomide, and dexamethasone for multiple myeloma with CNS involvement.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Pomalidomide (Pomalidomide)
• Selinexor (selinexor)

Snippet

Sponsor: Peking University People's Hospital | Conditions: Multiple Myeloma | Phase 2 | Status: UNKNOWN